Compounds > lexapro
Page last updated: 2024-09-04

lexapro and norfloxacin

lexapro has been researched along with norfloxacin in 1 studies

Compound Research Comparison

Studies
(lexapro)		Trials
(lexapro)		Recent Studies (post-2010)
(lexapro)		Studies
(norfloxacin)		Trials
(norfloxacin)		Recent Studies (post-2010) (norfloxacin)
170123,077280912

Protein Interaction Comparison

ProteinTaxonomylexapro (IC50)norfloxacin (IC50)
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)0.02
DNA gyrase subunit AEscherichia coli K-120.6
DNA gyrase subunit BEscherichia coli K-120.6
DNA topoisomerase 4 subunit AStaphylococcus aureus3.5
Cytochrome P450 2C9 Homo sapiens (human)2.56
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)0.02
Cytochrome P450 2J2Homo sapiens (human)2.56
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)0.02
GABA theta subunitRattus norvegicus (Norway rat)0.02
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)0.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1

Other Studies

1 other study(ies) available for lexapro and norfloxacin

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013